Cargando…

Epidermal Growth Factor Receptor: A Potential Therapeutic Target for Diabetic Kidney Disease

Diabetic kidney disease (DKD) is a leading cause of end-stage renal disease worldwide and the major cause of renal failure among patients on hemodialysis. Numerous studies have demonstrated that transient activation of epidermal growth factor receptor (EGFR) pathway is required for promoting kidney...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sheng, Lili, Bayliss, George, Zhuang, Shougang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870700/ https://www.ncbi.nlm.nih.gov/pubmed/33574751 http://dx.doi.org/10.3389/fphar.2020.598910

Ejemplares similares

Histone Methyltransferases as Therapeutic Targets for Kidney Diseases
por: Yu, Chao, et al.
Publicado: (2019)

New Insights Into the Effects of Individual Chinese Herbal Medicines on Chronic Kidney Disease
por: Shao, Minghai, et al.
Publicado: (2021)

Role of epidermal growth factor receptor in acute and chronic kidney injury
por: Tang, Jinhua, et al.
Publicado: (2013)

Cardiotoxicity of Epidermal Growth Factor Receptor 2-Targeted Drugs for Breast Cancer
por: Yang, ZiYan, et al.
Publicado: (2021)

Protein arginine methyltransferases in renal development, injury, repair, and fibrosis
por: Yu, Jianjun, et al.
Publicado: (2023)

Therapeutic Effect of Epidermal Growth Factor Combined With Nano Silver Dressing on Diabetic Foot Patients
por: Zhang, Kaihua, et al.
Publicado: (2021)

Modulation of Pathological Pain by Epidermal Growth Factor Receptor
por: Borges, Jazlyn P., et al.
Publicado: (2021)

The Role of Epidermal Growth Factor Receptor Family of Receptor Tyrosine Kinases in Mediating Diabetes-Induced Cardiovascular Complications
por: Shraim, Bara A., et al.
Publicado: (2021)

Cholesterol Crystal Embolism and Chronic Kidney Disease
por: Li, Xuezhu, et al.
Publicado: (2017)

Histone Methyltransferase EZH2: A Potential Therapeutic Target for Kidney Diseases
por: Li, Tingting, et al.
Publicado: (2021)

Immune Responses to Epidermal Growth Factor Receptor (EGFR) and Their Application for Cancer Treatment
por: Sasada, Tetsuro, et al.
Publicado: (2016)

Non-Coding RNAs as Biomarkers and Therapeutic Targets for Diabetic Kidney Disease
por: Gu, Yue-Yu, et al.
Publicado: (2021)

Cellular Senescence and the Kidney: Potential Therapeutic Targets and Tools
por: Knoppert, Sebastian N., et al.
Publicado: (2019)

The Role of the Epidermal Growth Factor Receptor in Diabetic Kidney Disease
por: Harris, Raymond C.
Publicado: (2022)

The Role and Mechanism of Histone Deacetylases in Acute Kidney Injury
por: Zhou, Xun, et al.
Publicado: (2021)

The Role and Mechanism of Lysine Methyltransferase and Arginine Methyltransferase in Kidney Diseases
por: Zhou, Xun, et al.
Publicado: (2022)

Nuclear epidermal growth factor receptor as a therapeutic target
por: Atwell, Benjamin, et al.
Publicado: (2023)

Receptor Interacting Protein Kinases 1/3: The Potential Therapeutic Target for Cardiovascular Inflammatory Diseases
por: Leng, Yiming, et al.
Publicado: (2021)

Comparative Proteomics Analysis Reveals the Reversal Effect of Cryptotanshinone on Gefitinib-Resistant Cells in Epidermal Growth Factor Receptor-Mutant Lung Cancer
por: Cai, Peiheng, et al.
Publicado: (2022)

Interactions of ABCG2 (BCRP) with epidermal growth factor receptor kinase inhibitors developed for molecular imaging
por: Qawasmi, Israa, et al.
Publicado: (2014)

Podocyte Autophagy: A Potential Therapeutic Target to Prevent the Progression of Diabetic Nephropathy
por: Liu, Na, et al.
Publicado: (2017)

Metabolic reprogramming: A novel therapeutic target in diabetic kidney disease
por: Wang, Mengdi, et al.
Publicado: (2022)

Teriflunomide Is an Indirect Human Constitutive Androstane Receptor (CAR) Activator Interacting With Epidermal Growth Factor (EGF) Signaling
por: Carazo, Alejandro, et al.
Publicado: (2018)

Free fatty acid receptors as therapeutic targets for the treatment of diabetes
por: Ichimura, Atsuhiko, et al.
Publicado: (2014)

Class IIa histone deacetylase inhibition ameliorates acute kidney injury by suppressing renal tubular cell apoptosis and enhancing autophagy and proliferation
por: Li, Jialu, et al.
Publicado: (2022)

Targeting the epidermal growth factor receptor
por: El-Rayes, B F, et al.
Publicado: (2004)

New Insights Into the Role and Mechanism of Partial Epithelial-Mesenchymal Transition in Kidney Fibrosis
por: Sheng, Lili, et al.
Publicado: (2020)

Taurine and Epidermal Growth Factor Belong to the Signature of First-Episode Psychosis
por: Koido, Kati, et al.
Publicado: (2016)

Significant metabolic alterations in non-small cell lung cancer patients by epidermal growth factor receptor-targeted therapy and PD-1/PD-L1 immunotherapy
por: Yan, Chen, et al.
Publicado: (2022)

Inhibition of polycomb repressive complex 2 by targeting EED protects against cisplatin‐induced acute kidney injury
por: Yu, Chao, et al.
Publicado: (2022)

Histone Acetylation and Modifiers in Renal Fibrosis
por: Shen, Fengchen, et al.
Publicado: (2022)

Editorial: Matricellular Receptors As Potential Targets in Anti-Cancer Therapeutic Strategies
por: Emonard, Hervé, et al.
Publicado: (2016)

Caveolin-1 Regulates Cellular Metabolism: A Potential Therapeutic Target in Kidney Disease
por: Luo, Shilu, et al.
Publicado: (2021)

TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review
por: Zixin, Ye, et al.
Publicado: (2022)

The Cardenolide Glycoside Acovenoside A Interferes with Epidermal Growth Factor Receptor Trafficking in Non-Small Cell Lung Cancer Cells
por: Hafner, Susanne, et al.
Publicado: (2021)

Pathophysiological Mechanisms and Potential Therapeutic Targets in Intracerebral Hemorrhage
por: Shao, Zhiwei, et al.
Publicado: (2019)

Pharmacologic Targeting of BET Proteins Attenuates Hyperuricemic Nephropathy in Rats
por: Xiong, Chongxiang, et al.
Publicado: (2021)

Role of matrix metalloproteinases in diabetic foot ulcers: Potential therapeutic targets
por: Fu, Kang, et al.
Publicado: (2022)

Therapeutic targeting of epidermal growth factor receptor in human cancer: successes and limitations
por: Wykosky, Jill, et al.
Publicado: (2011)

Sorting nexin-dependent therapeutic targeting of oncogenic epidermal growth factor receptor
por: Atwell, Benjamin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v4dqkaslhtplpat4s3rp0eh9u9